Mathai Mammen Johnson & Johnson (JNJ) insider trading activity

JNJ Quotes by TradingView

Mathai Mammen is EVP, Pharm, R&D of JOHNSON & JOHNSON. Currently has a direct ownership of 41,934 shares of JNJ, which is worth approximately $6.5 Million. The most recent transaction as insider was on Feb 15, 2022, when has been sold 3,366 shares (Common Stock) at a price of $165.89 per share, resulting in proceeds of $558,386. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.9K
0% 3M change
0% 12M change
Total Value Held $6.5 Million

Mathai Mammen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2022
SELL
Payment of exercise price or tax liability
$558,386 $165.89 p/Share
3,366 Reduced 7.43%
41,934 Common Stock
Feb 15 2022
BUY
Exercise of conversion of derivative security
-
7,740 Added 14.59%
45,300 Common Stock
Feb 14 2022
SELL
Payment of exercise price or tax liability
$394,265 $168.85 p/Share
2,335 Reduced 5.85%
37,560 Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
-
7,418 Added 15.68%
39,895 Common Stock

Also insider at

TXG
10x Genomics, Inc. Healthcare
MM

Mathai Mammen

EVP, Pharm, R&D
New Brunswick, NJ

Track Institutional and Insider Activities on JNJ

Follow JOHNSON & JOHNSON and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

News

Receive news related to JOHNSON & JOHNSON

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JNJ